TSHA
USDTaysha Gene Therapies Inc. Common Stock
$4.270-0.020 (-0.466%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$4.290
High
$4.540
Low
$4.000
Volume
5.02M
Company Fundamentals
Market Cap
1.2B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
6.14M
Exchange
NMS
Currency
USD
52-Week Range
Low $1.05Current $4.270High $5.508
Related News
Analyst Upgrades
Raymond James Initiates Coverage On Taysha Gene Therapies with Strong Buy Rating, Announces Price Target of $13
Raymond James analyst Christopher Raymond initiates coverage on Taysha Gene Therapies with a Strong Buy rating and announces Price Target of $13.
View more
GlobeNewswire
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
DALLAS, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (NASDAQ:TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.